Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma.

Amir Amirabadi Amir Hossein AalamiHamid AhanchianNazila AriaeeNasrin Moazzen

Published in: Clinical case reports (2021)

Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it.

Keyphrases

basal cell carcinoma
epidermal growth factor receptor
tyrosine kinase
advanced non small cell lung cancer
locally advanced
case report
clinical practice
current status
squamous cell carcinoma
radiation therapy
combination therapy
rectal cancer
smoking cessation
chemotherapy induced